---
figid: PMC5295849__jleub2A0316-141RRf9
figlink: /pmc/articles/PMC5295849/figure/F9/
number: F9
caption: CXCL12 activates Rac1 and class I PI3Ks in BMM, presumably via CXCR4. Rac1
  stimulates membrane ruffling and macropinocytic cup formation. Class I PI3Ks also
  regulate MP formation and generate PIP3 and/or PI(3,4)P2 in the cup (green). Akt
  is then recruited to the cup structure and phosphorylated. pAkt induces pTSC2 (deactivation
  of TSC2). PKC function is required for cup closure. Given that PKC is regulated
  by DAG (blue), which is generated by PLCγ, the PLCγ/DAG pathway likely acts upstream
  of PKC in MP formation. Whereas the Akt/TSC pathway activates Rheb, the macropinocytic
  pathway conveys extracellular nutrients to the lysosome to activate Rag. Thus, these
  2 pathways coordinately activate mTORC1. EIPA blocks macropinocytosis by inhibiting
  Rac1 function. J/B block membrane ruffling, as well as macropinocytosis. Staurosporine
  (Stauro), calphostin C (CalC), and Gö6976 (Go) all block MP closure by inhibiting
  PKC function. MK2206 (MK) inhibits Akt function but not macropinocytosis. p110 isoform-specific
  inhibitors block cup formation and cup closure, resulting in the attenuation of
  mTORC1 activity.
pmcid: PMC5295849
papertitle: CXCL12-induced macropinocytosis modulates two distinct pathways to activate
  mTORC1 in macrophages.
reftext: Regina Pacitto, et al. J Leukoc Biol. 2017 Mar;101(3):683-692.
pmc_ranked_result_index: '106336'
pathway_score: 0.9392694
filename: jleub2A0316-141RRf9.jpg
figtitle: Proposed model of CXCL12 signaling to mTORC1 in BMM
year: '2017'
organisms:
- Homo sapiens
ndex: 23ddf7cc-dea9-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5295849__jleub2A0316-141RRf9.html
  '@type': Dataset
  description: CXCL12 activates Rac1 and class I PI3Ks in BMM, presumably via CXCR4.
    Rac1 stimulates membrane ruffling and macropinocytic cup formation. Class I PI3Ks
    also regulate MP formation and generate PIP3 and/or PI(3,4)P2 in the cup (green).
    Akt is then recruited to the cup structure and phosphorylated. pAkt induces pTSC2
    (deactivation of TSC2). PKC function is required for cup closure. Given that PKC
    is regulated by DAG (blue), which is generated by PLCγ, the PLCγ/DAG pathway likely
    acts upstream of PKC in MP formation. Whereas the Akt/TSC pathway activates Rheb,
    the macropinocytic pathway conveys extracellular nutrients to the lysosome to
    activate Rag. Thus, these 2 pathways coordinately activate mTORC1. EIPA blocks
    macropinocytosis by inhibiting Rac1 function. J/B block membrane ruffling, as
    well as macropinocytosis. Staurosporine (Stauro), calphostin C (CalC), and Gö6976
    (Go) all block MP closure by inhibiting PKC function. MK2206 (MK) inhibits Akt
    function but not macropinocytosis. p110 isoform-specific inhibitors block cup
    formation and cup closure, resulting in the attenuation of mTORC1 activity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CXCL12
  - PRKCI
  - MTOR
  - RPTOR
  - AKT2
  - MICU1
  - PRKCH
  - AKT1
  - PRKCQ
  - PRKCZ
  - SART3
  - CXCR4
  - PRKCA
  - PRKCD
  - PRKCB
  - PRKCG
  - PRKD3
  - RAC1
  - PLCG1
  - AKT3
  - TSC2
  - PRKCE
  - TSC1
  - EIPA
  - Cancer
genes:
- word: CXCL12
  symbol: CXCL12
  source: hgnc_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: CalC,
  symbol: CALC
  source: hgnc_alias_symbol
  hgnc_symbol: MICU1
  entrez: '10367'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: CXCR4?
  symbol: CXCR4
  source: hgnc_symbol
  hgnc_symbol: CXCR4
  entrez: '7852'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: Rac1
  symbol: RAC1
  source: hgnc_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: PLCY1?-
  symbol: PLCG1
  source: hgnc_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: TSC1/2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: TSC1/2
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
chemicals:
- word: EIPA
  source: MESH
  identifier: C039614
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC5295849__F9
redirect_from: /figures/PMC5295849__F9
figtype: Figure
---
